TIPCO Engineering Delivers Breakout H2 FY26: Net Profit Soars 157% with EBITDA Surging 134%

New Delhi [India], May 28:Tipco Engineering India Limited, (BSE SME- 544740, TIPCO | INE1U6D01014), an integrated manufacturer of industrial process equipment, has reported its Audited financials for H2 FY26 & FY26.

H2 FY26 Standalone Key Financial Highlights

  • Total Income of ₹ 95.81 Cr, YoY growth of 66.39%
  • EBITDA of ₹ 25.24 Cr, YoY growth of 133.59%
  • EBITDA Margin of 26.34%, YoY growth of 758 Bps
  • Net Profit of ₹ 16.73 Cr, YoY growth of 157.03%
  • Net Profit Margin of 17.46%, YoY growth of 616 Bps
  • Diluted EPS of ₹ 10.86, YoY growth of 155.53%

FY26 Standalone Key Financial Highlights

Diluted EPS of ₹ 16.44, YoY growth of 65.06%

Total Income of ₹ 146.07 Cr, YoY growth of 9.54%

EBITDA of ₹ 38.90 Cr, YoY growth of 62.46%

EBITDA Margin of 26.63%, YoY growth of 867 Bps

Net Profit of ₹ 25.31 Cr, YoY growth of 65.78%

Net Profit Margin of 17.32%, YoY growth of 588 Bps

Diluted EPS of ₹ 16.44, YoY growth of 65.06%

Commenting on the performance, Mr. Ritesh Sharma, Chairman & Managing Director, Tipco Engineering India Limited, said: “FY26 marks a defining phase in Tipco’s journey, with our successful listing on the BSE SME platform providing a strong foundation for accelerated and sustainable growth. Built on over 35 years of trust and execution excellence, we have entered this new phase with strengthened financials, enhanced credibility, and a clear strategic direction.

Our performance reflects the strength of our business model, with EBITDA margins expanding by 867 basis points to 26.63%, supported by improved efficiencies, operating leverage, and disciplined cost management. The robust increase in profitability highlights our focused approach towards high-value opportunities. Our international technology collaboration has further strengthened our presence in pharmaceuticals, food, and cosmetics, while approvals for defence applications and capacity expansion position us well for future growth.

We are witnessing strong industry tailwinds across industrial and process equipment, supported by rising investments in manufacturing and capacity expansion. With a growing order pipeline, strengthened balance sheet post listing, and continued focus on strategic partnerships, we remain confident of scaling our operations in a calibrated manner and delivering sustained long-term value to all stakeholders.

If you object to the content of this press release, please notify us at pr.error.rectification@gmail.com. We will respond and rectify the situation within 24 hours.

Related Posts

Liquide’s Draws 1,500+ Seasoned Traders to Conclave 5.0 as AI Reshapes India’s Trading Landscape

 Left to Right: Kunal Ambasta – CIO & Co-Founder, Paritosh Gunjan – CTO & Co-Founder, Anuj Bajpai – CEO & Co-Founder Bengaluru (Karnataka) [India], September 28: Liquide Solutions, India’s leading…

Sollfege Smart Electronics’ IPO to Open on September 30, 2026; Company Aims to Raise Rs. 21.78 Crore

IPO proceeds to support expansion of retail network through 12 new showrooms, working capital requirements and general corporate purposes Kolkata (West Bengal) [India], September 28: Sollfege Smart Electronics Limited (“Company”),…

You Missed

Liquide’s Draws 1,500+ Seasoned Traders to Conclave 5.0 as AI Reshapes India’s Trading Landscape

Liquide’s Draws 1,500+ Seasoned Traders to Conclave 5.0 as AI Reshapes India’s Trading Landscape

Sollfege Smart Electronics’ IPO to Open on September 30, 2026; Company Aims to Raise Rs. 21.78 Crore

Sollfege Smart Electronics’ IPO to Open on September 30, 2026; Company Aims to Raise Rs. 21.78 Crore

Dr. A.K. Dwivedi Presents Second Edition of ‘Homeopathy for Anemia’ to CM Mohan Yadav

Dr. A.K. Dwivedi Presents Second Edition of ‘Homeopathy for Anemia’ to CM Mohan Yadav

Eventions’ IPO to Open on September 30, 2026; Company Aims to Raise Rs. 38.12 Crore

Eventions’ IPO to Open on September 30, 2026; Company Aims to Raise Rs. 38.12 Crore

Blood Cancer in 2026: Why Treatment Decisions Are More Personal Than Ever

Blood Cancer in 2026: Why Treatment Decisions Are More Personal Than Ever

Bamboo Pitched as ‘Green Gold’ for Rural India at Mumbai Summit

Bamboo Pitched as ‘Green Gold’ for Rural India at Mumbai Summit